Export of "Hemofarm" larger by 35% - profit in amount of 95m EUR

Total export of pharmaceutical company "Hemofarm" has grown during this year by 35%, which brought profit in amount of 95m EUR to that company on the foreign market - said President of "Hemofarm", Miodrag Babić, at the New Year cocktail for the media representatives.

- All our units have European manufacturing practice, which enables export of our products to west European countries. We will enter American market at the beginning of the next year, which will clear us the path to Canada and Japan. The share of "Hemofarm" on domestic market is 26%. This company exports to 27 countries on all four continents and the largest export market of "Hemofarm" is Russia where, among more than 2,000 suppliers, this company exports more than 50% of its total export - said Babić.